Emelie Berglund

1.0k total citations
7 papers, 396 citations indexed

About

Emelie Berglund is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Emelie Berglund has authored 7 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Emelie Berglund's work include Prostate Cancer Treatment and Research (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Molecular Biology Techniques and Applications (3 papers). Emelie Berglund is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Molecular Biology Techniques and Applications (3 papers). Emelie Berglund collaborates with scholars based in Sweden, Taiwan and United Kingdom. Emelie Berglund's co-authors include Joakim Lundeberg, Ludvig Larsson, Stefanie Friedrich, Thomas Helleday, Anna Tanoglidi, Niklas Schultz, Erik L. L. Sonnhammer, Firas Tarish, Maja Marklund and Jens Lagergren and has published in prestigious journals such as Nature Communications, BMC Genomics and PharmacoEconomics.

In The Last Decade

Emelie Berglund

6 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emelie Berglund Sweden	4	296	133	77	68	61	7	396
Stefanie Friedrich Sweden	5	380 1.3×	138 1.0×	76 1.0×	69 1.0×	59 1.0×	6	472
Maja Marklund Sweden	4	323 1.1×	143 1.1×	81 1.1×	79 1.2×	63 1.0×	4	422
Firas Tarish Sweden	4	299 1.0×	140 1.1×	106 1.4×	68 1.0×	108 1.8×	4	418
Kim Thrane Sweden	6	350 1.2×	114 0.9×	73 0.9×	113 1.7×	21 0.3×	10	429
Mingyu Yang China	5	519 1.8×	121 0.9×	63 0.8×	119 1.8×	40 0.7×	9	626
Ghamdan Al‐Eryani Australia	4	320 1.1×	125 0.9×	100 1.3×	143 2.1×	17 0.3×	11	430
Benedict Anchang United States	7	253 0.9×	95 0.7×	122 1.6×	55 0.8×	19 0.3×	18	378
Yu Weng China	11	186 0.6×	133 1.0×	83 1.1×	26 0.4×	33 0.5×	14	333
Joon Sang Lee United States	2	147 0.5×	60 0.5×	55 0.7×	32 0.5×	51 0.8×	2	245
Satoi Nagasawa Japan	9	280 0.9×	117 0.9×	77 1.0×	40 0.6×	21 0.3×	16	379

Countries citing papers authored by Emelie Berglund

Since Specialization

Citations

This map shows the geographic impact of Emelie Berglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emelie Berglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emelie Berglund more than expected).

Fields of papers citing papers by Emelie Berglund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emelie Berglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emelie Berglund. The network helps show where Emelie Berglund may publish in the future.

Co-authorship network of co-authors of Emelie Berglund

This figure shows the co-authorship network connecting the top 25 collaborators of Emelie Berglund. A scholar is included among the top collaborators of Emelie Berglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emelie Berglund. Emelie Berglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pang, See‐Tong, Emelie Berglund, I‐Hung Shao, et al.. (2025). First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer. BJUI Compass. 6(6). e70026–e70026. 1 indexed citations

2.

Frisell, Oskar, et al.. (2025). Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice. PharmacoEconomics. 43(5). 509–520. 1 indexed citations

3.

Marklund, Maja, Niklas Schultz, Stefanie Friedrich, et al.. (2022). Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones. Nature Communications. 13(1). 5475–5475. 8 indexed citations

4.

Berglund, Emelie, Sami Saarenpää, Anders Jemt, et al.. (2020). Automation of Spatial Transcriptomics library preparation to enable rapid and robust insights into spatial organization of tissues. BMC Genomics. 21(1). 298–298. 18 indexed citations

5.

Berglund, Emelie, Jonas Maaskola, Niklas Schultz, et al.. (2018). Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. Nature Communications. 9(1). 2419–2419. 343 indexed citations

6.

Borgström, Erik, et al.. (2015). Phasing of single DNA molecules by massively parallel barcoding. Nature Communications. 6(1). 7173–7173. 25 indexed citations

7.

Berglund, Emelie, et al.. (2013). Financial ratios ability to predict excess returns of Swedish listed firms. Lund University Publications Student Papers (Lund University).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact